Guidance held, but Q1 reality undermines it
Management maintained the ₹800 crore FY27 revenue target despite Q1 revenue falling 15% YoY and profit collapsing 50%. The call reveals why: the guidance is now contingent on external recovery, not operational momentum.
₹134.6 Cr
–15.2% YoY, –11.2% QoQ
₹20.9 Cr
–49.7% YoY, –26.5% QoQ
16.4%
vs 29% historical (229 bps miss)
60–65%
vs ~100% target
₹500 Cr
30% export, 70% domestic
Management held the ₹800 crore FY27 revenue target unchanged despite Q1 delivering a 15.2% year-on-year revenue decline and a 49.7% profit collapse. The call makes clear why: the guidance is now contingent on an external recovery (West Asia shipping normalization, export order unfreezing) rather than grounded in operational momentum. Capacity utilization at 60–65% vs. a full-utilization target, profit declining faster than revenue, and margins compressed 229 basis points against historical 29% levels signal a quarter that underperformed, with recovery hedged on factors outside management's control.
Where the profit collapse came from
The 49.7% profit decline outpaced the 15.2% revenue decline because management achieved only 50–60% pass-through of raw material price increases on Q4/Q1 backlog orders; the remainder hit operating margin. Q1 operating margin compressed to 16.4% from a historical 29%, a gap of 1,260 basis points. On ₹134.6 crore revenue, that margin gap cost roughly ₹17 crore in operating profit annually. EBITDA at 21.7% (₹29.23 Cr) reflects trough conditions per management, but the path to restoring the 29% target remains unquantified and is now explicitly contingent on export recovery—a material shift from prior calls.
West Asia crisis cost ₹30–35 Cr in Q1 revenue opportunity
Q1 at ₹134.6 Cr is well below the run-rate needed for ₹800 Cr FY27 target; supports the loss quantification
Supported
Only 50–60% cost pass-through on Q4/Q1 orders
Q1 OPM of 16.4% vs 29% historical confirms majority of raw material inflation absorbed
Supported
New orders at current market prices; no margin pressure expected
Management refuses to quantify ₹500 Cr order book margin profile (only says 'reasonable margins') despite 70% domestic mix (lower-margin) and prior cost absorption failure
Dodged
Capacity utilization 60–65% confirms supply-side constraint, not demand collapse
Confirmed; but 35–40 pp miss vs. FY27 target is material and unexplained beyond geopolitical
Confirmed (but concerning)
₹500 Cr order book covers Q2–Q4 execution
₹500 Cr OB / 3 quarters = ₹167 Cr/quarter avg; requires only 24% uptick from Q1 ₹135 Cr, not the 65% ramp needed for ₹800 Cr FY27
Overstated
FY27 ₹800 Cr target remains on track
Q1 ₹134.6 Cr requires Q2–Q4 avg of ₹222 Cr (65% jump from Q1); target now hedged on West Asia normalization, not operational certainty
Increasingly hedged
What changed on this call
Guidance hedging: Q4 FY26 call expected April recovery; Q1 reality shows crisis extended into May, exports still depressed, guidance now explicitly contingent on West Asia normalization. Margin outlook downgrade: Historical 29% EBITDA target now conditional on export recovery; if domestic-focused, management warns of a 'slight dip.' Q1 at 21.7% with no quantified path to restoration. Export/domestic mix deterioration: Order book now 70% domestic vs. historical higher export concentration. Domestic carries ~10% lower margin per management; this structural shift pressures average profitability even if volumes recover. Capacity utilization miss: Q1 at 60–65% vs. FY27 target ~100% (implied near-full-capacity run). A 35–40 pp miss beyond what geopolitical shock alone explains.
How the market is positioned
The market has already rendered its verdict on the print. The stock fell 15.77% on day 1 post-announcement (delivery 48.4%), and the decline persisted—still down 13.81% by day 5. This is not a whipsaw pop-and-fade; it is a sustained repricing. The stock now trades at ₹3944, down 26.95% from its all-time high of ₹5399, and sits below its 20-day (₹4338) and 50-day (₹4357) moving averages. Institutional flows show no panic—FII and DII flat QoQ, promoter ownership flat—but the absence of bottom-fishing is itself telling. The market is not seeing a dip to accumulate; it is seeing a loss of credibility on guidance. RSI at 32.9 (neutral) and rising volume suggest the repricing is on selling, not capitulation bounce.
₹500 Cr order book provides Q2–Q4 visibility and execution hedge
Phase-3 expansion (6,500 MVA, April 2027) is on track; concrete growth runway
Management quantified crisis impact (₹30–35 Cr loss, 3–5x shipping costs, 50–60% cost pass-through); transparency on headwinds
Q1 revenue down 15% YoY, profit down 50% YoY; severe operational miss
Only 50–60% cost absorption on backlog; margin path to 29% unquantified
Capacity utilization 60–65% vs. ~100% target; 35–40 pp miss unexplained by geopolitical alone
Annual report optimistic (June) vs. Q1 disappoints; credibility damaged by wrong macro forecast
Order book 70% domestic (vs. historical higher export); structurally depresses average margin ~10%
Guidance maintained despite 15% revenue decline; severe hedging or over-optimism
West Asia crisis persists; shipping costs remain 3–5x elevated
High30% of order book is export-exposed. If container costs stay elevated and geopolitical tensions persist, export orders remain frozen. This is the lynchpin of the FY27 ₹800 Cr case and margin restoration to 29%.
Margin compression structural; domestic mix squeeze
HighOrder book now 70% domestic (vs. historical higher export); domestic carries ~10% lower margin per management. If export recovery fails, average margin stuck near 20–22%, not 29%. Analyst noted competitors thriving on domestic—pricing war risk if demand doesn't recover.
Capacity underutilization persists; demand weakness signal
HighQ1 at 60–65% vs. ~100% target is a 35–40 pp miss. If this reflects demand weakness (not just geopolitical), H2 normalization may not deliver the 65% revenue jump needed for ₹800 Cr. Phase-3 addition (April 2027) will worsen utilization if demand doesn't accelerate.
Guidance credibility erosion; forecast accuracy in question
MediumAnnual report (June, prepared May) was optimistic on April recovery; Q1 shows May persistence of crisis, 60–65% utilization. If management misforecasts again in H2, ₹800 Cr could miss by ₹100–150 Cr. Analyst pushback on execution was sharp; further misses erode credibility.
220 KV market entry execution risk; new product ramp
MediumPhase-3 adds capacity for new higher-voltage products. Customer qualification/audit required (3–4 months); initially lower margins for market entry. If qualification delays or adoption slower than expected, Phase-3 capacity underutilized.
Order book margin profile opaque; execution risk hidden
MediumManagement refused to quantify ₹500 Cr order book margin profile (only 'reasonable margins'). Given 70% domestic and prior 50–60% cost pass-through failure, OB likely carries 18–22% EBITDA, not 25%+ needed for FY27 ₹800 Cr at 29%. Silent margin miss risk.
1 · Q2 revenue and margin (due Oct 2026)
Does the ₹500 Cr order book begin to execute? Expect ₹165–180 Cr revenue minimum and movement toward 20%+ EBITDA. If Q2 is flat or lower, the 65% Q2–Q4 ramp required for ₹800 Cr is no longer credible.
2 · Export order unfreezing (Sep–Nov 2026)
Shipping costs normalizing? New export orders placed? Q2 call should reveal visibility on West Asia recovery and customer inquiries. Absence of improvement is a red flag on the bull thesis.
3 · Phase-3 commissioning and 220 KV ramp (Apr 2027 onward)
Capacity added; customer qualification progress visible. If prototyping extends beyond 4 months or adoption sluggish, Phase-3 becomes a capacity sink rather than growth driver.
Shilchar's Q1 was a step-change down, not a stumble. Profit fell 50%, margins compressed 229 bps, and capacity ran at 60–65%. Management held guidance, but the call made clear it is now heavily contingent on an external recovery (West Asia normalization, export unfreezing) and a domestic pivot only 3–4 months into execution. The company has concrete upside—₹500 Cr order book and Phase-3 expansion—but near-term credibility is in question after missing on Q1 execution and forecasting wrong on macro. The rebound is real if West Asia normalizes by H2 and order book executes; it is a significant miss if not.
Stock is down 27% from ATH and below key averages; the repricing has room to run if Q2 disappoints. The number to track from here is organic EBITDA margin: if Q2 comes in below 20%, the FY27 guidance is in trouble.
Shilchar Q1 FY27: PAT -50% YoY on margin compression, revenue -15%, off guided pace
PAT -49.7% YoY · revenue -15.2% · margins compressing
₹134.61 Cr
-15.2% YoY
₹20.86 Cr
-49.7% YoY
14.72%
-10.7pp YoY
₹18.24
Shilchar Technologies filed only a standalone result (the company runs a single segment, Transformers & Parts, and does not file a consolidated statement) for Q1 FY27, and it's a weak YoY print. Revenue from operations fell 15.2% year-on-year to ₹134.61 Cr (₹158.75 Cr in Q1 FY26) and standalone net profit dropped 49.7% to ₹20.86 Cr (₹41.49 Cr a year ago); basic EPS nearly halved to ₹18.24 from ₹36.27. The weakness isn't just a tough base effect — sequentially, revenue is down 11.2% and PAT down 26.5% against Q4 FY26 (₹151.65 Cr revenue, ₹28.39 Cr PAT), making this the second straight soft quarter.
Q1 FY-2027 vs prior quarters
The margin bridge points squarely at input costs: cost of materials consumed rose to 68.1% of revenue (₹91.67 Cr on ₹134.61 Cr) from 57.5% a year ago (₹91.34 Cr on ₹158.75 Cr), even as revenue itself shrank — a combination that pulled operating margin down to roughly 15.6% from about 33.0% in Q1 FY26 and 21.0% last quarter, with net margin falling to 14.7% from 25.5% YoY. There are no exceptional items in the statement and the tax rate held steady near 25-26% across all three periods, so the profit decline is entirely operating, not a one-off. A positive ₹6.31 Cr "changes in inventories" charge (versus a ₹1.16 Cr inventory build in Q4 FY26) suggests finished-goods stock was drawn down this quarter rather than added to.
The stock went into the print at ₹4,576, up 1.8% over the past month of trading.
Management provides a conservative revenue guidance of INR 800-850 crores for FY27, to be achieved by running existing capacity at near-full utilization. They aim to restore EBITDA margins to historical levels (~29%) by negotiating price hikes to counter significant commodity inflation. Long-term growth will be driven
— This quarter: missed
No formal analyst consensus for this quarter turned up in a search, so vs-street is unknown; external reports around the FY26 close had flagged roughly ₹35-40 Cr of Middle East export shipments deferred out of Q4 FY26 into Q1 FY27 on logistics disruptions, plus elevated closing inventory earmarked for early dispatch — both would have been tailwinds to this quarter's revenue, yet the print still declined both YoY and QoQ, implying the underlying run-rate was softer than those catch-up dispatches alone would suggest. Against management's own FY27 guidance from the June-quarter concall — ₹800-850 Cr revenue and an EBITDA margin recovery toward the ~29% historical level via price hikes to offset commodity inflation — this quarter is off pace on both counts: ₹134.61 Cr in Q1 needs the remaining three quarters to average ₹222-238 Cr to reach the low end of guidance, and margin moved further from 29% rather than toward it. No management press release accompanied this filing to explain the shortfall.
W1
Whether management's flagged price hikes restore EBITDA margin toward the ~29% historical level — OPM was just ~15.6% this quarter, the toughest test yet of that plan
W2
Revenue trajectory against the ₹800-850 Cr FY27 guidance — Q1 at ₹134.61 Cr requires a sharp ramp (~₹222-238 Cr/quarter average) in the remaining three quarters to reach the low end
W3
Progress on the capacity-doubling expansion slated for April 2027, which management ties to a potential ₹1,500 Cr FY28 turnover
West Asia crisis derails Q1; recovery hedged on export normalization
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Annual report (July, prepared June) was optimistic on West Asia recovery; Q1 reality contradicted it. Management now contingent on export normalization.
Neutral
next 1–2 quarters
Cautiously Optimistic
multi-year
Q1 delivered -15% revenue, -50% PAT, 229 bps margin miss vs historical 29% on unabsorbed raw material costs and export mix shift. FY27 ₹800 Cr guidance maintained but increasingly hedged on West Asia normalization and export recovery. Phase-3 expansion is concrete (April 2027), but initial 220 KV margins will be depressed. Key risk: if West Asia crisis persists and export share remains ~30%, FY27 margin guidance credibility erodes further.
₹134.6 Cr
Revenue · −15.2% YoY₹20.9 Cr
Reported PAT · −49.7% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
West Asia crisis caused ₹30-35 Cr revenue loss in Q1
METQ1 revenue ₹134.6 Cr implies ~65% of run-rate needed for ₹800 Cr FY27 target
Only 50-60% raw material price increase passed to customers
METQ1 margin 16.4% OPM vs 29% historical indicates significant unabsorbed cost
Q1 capacity utilization 60-65%
METRevenue ₹134.6 Cr at below-target utilization confirms underrun
Order book ₹500 Cr, 70% domestic, 30% export
METWould deliver ₹500 Cr over Q2-Q4 at quarterly ~₹167 Cr run-rate
FY27 ₹800 Cr revenue target remains on track
OVERSTATEDQ1 ₹134.6 Cr requires average ₹222 Cr/quarter for remaining 3Q—65% jump from Q1
EBITDA margins can restore to 29% if exports recover
MISSQ1 at 21.7% EBITDA margin; 229 bps gap with zero commentary on path back
Earnings quality
What changed since the last call
Revenue guidance hedging
DowngradeQ4 FY26 call expected recovery from April; Q1 actual shows 60-65% capacity use, exports still depressed. ₹800 Cr now contingent on Q2-Q4 averaging 65% higher than Q1.
EBITDA margin outlook
DowngradeHistorical 29% guidance now conditional on export recovery; Q1 at 21.7% with no quantified path to restoration. Domestic mix shift reduces average margin ~10%.
Export/domestic mix
DowngradeOrder book now 70% domestic vs historical higher export. Shipping costs (3-5x) have frozen exports; customer shift to minimum-volume purchasing.
Capacity utilization
DowngradeQ1 at 60-65% vs FY27 full-utilization target. Reflects both geopolitical impact and lower-than-expected demand.
The Q&A
Analysts pressed hard on execution credibility. Aman Soni and Manoj Desai highlighted gap between optimistic annual report (June, prepared) and soft Q1 delivery—management conceded wrong assumption on West Asia resolution. Abhigayan challenged management's failure to proactively pivot to domestic earlier; noted competitors thriving on domestic market in Q1. Venil Shah pushed on guidance revision; management refused to lower ₹800 Cr target despite 65% utilization and margin miss. Q&A reveals skepticism on execution and margin recovery narrative.
Revenue loss quantification — Venil Shah, Dalal & Broacha
Partial₹30-35 Cr opportunity loss if crisis had not occurred; FY27 guidance remains on track.
Margin pressure and cost pass-through — Venil Shah, Dalal & Broacha
Answered50-60% pass-through on Q4/Q1 orders; new orders at current market prices, no margin pressure expected.
Order book and geographic split — Adesh Gosalia, Spark Capital
Answered₹500 Cr OB; 30% export, 70% domestic; execution across Q2-Q4; strong inquiry pipeline.
EBITDA margin sustainability — Jiten Parmar, Auram Capital
PartialIf exports recover, historical profitability maintained; if domestic-focused, slight dip. 220 KV initially lower for market entry, then recover.
West Asia crisis quantification and annual report gap — Aman Soni, 7 Alpha Investors
DodgedAnnual report prepared early June; at that time, expected West Asia to resolve soon based on announcements. Crisis persisted longer than expected.
Capacity utilization and proactive pivot — Manoj Salil Desai, Osillus Investment Managers
PartialQ1 at 60-65% utilization; expected normalization in April but shipping costs spiked end-May. Custom product lead time 10-16 weeks explains delay in domestic pivot.
Proactive management of export/domestic mix — Abhigayan, HA Capital
PartialExpected April normalization; sudden cost shock end-April/May halted exports. Took prompt action to shift to domestic; takes time to get orders (10-16 week lead time) and execute.
Capacity readiness and revenue ramp timeline — Aditya Dayal, Ziva Consultants
AnsweredWill produce existing range immediately; 220 KV prototyping/customer audit ~3-4 months; larger orders later.
Domestic market pricing pressure — Komal Iyer, NBG Investments
AnsweredNo pressure on domestic margins; market normal vs 2 years ago. Product mix for ₹800 Cr will be higher domestic if situation unchanged.
Export revenue permanence risk — Ritesh Khanna, Individual Investor
PartialCustomers prefer us for quality/service/lead time; not buying elsewhere, just cautious. Once normal, will recover.
Margin differential and order book margins — Adesh Gosalia, Spark Capital (follow-up)
DodgedDifficult to quantify percentage, but orders at current raw material prices; 'quite good margins, reasonable margins.'
Q1 margin sustainability — Adesh Gosalia, Spark Capital (follow-up)
PartialWill be higher. We hope to achieve more EBITDA.
Guidance
FY27 ₹800 Cr (unchanged from prior guidance)
LowQ1 ₹134.6 Cr implies Q2-Q4 average ₹222 Cr needed; 65% jump from Q1. Contingent on export recovery and West Asia normalization. At risk if shipping costs remain elevated.
EBITDA restoration to ~29% historical
LowHedged on export recovery. If domestic-focused, 'slight dip' expected. Q1 at 21.7%; path to 29% unquantified. 220 KV initially lower.
Phase-3 expansion (6,500 MVA) April 2027 commissioning
HighOn track; civil work complete; PEB erection/utilities progressing; all equipment ordered. May complete slightly ahead of schedule.
Risks the call surfaced
Geopolitical / Shipping costs
HighContainer costs 3-5x higher for Middle East/North America; customer purchasing frozen at minimum volumes; 30% of order book exposed.
Margin compression
HighDomestic revenue 70% of OB (vs historical higher export mix); domestic margin ~10% lower. Only 50-60% raw material cost pass-through on Q4/Q1 backlog; Q1 OPM 16.4% vs 29% historical.
Capacity underutilization
MediumQ1 utilization 60-65% vs FY27 target 'almost full' (near 100%); suggests either demand weakness or execution delay. Low utilization increases unit cost and reduces profitability.
Execution risk on Phase-3
Medium220 KV product new to company; customer audit/approval/type-testing required (3-4 months minimum); initially lower margins for market penetration; integration risk with existing operations.
Competitive intensity
MediumAnalyst notes competitors thriving on domestic market in Q1 (better numbers). If domestic focus is permanent, margin pressure from competition likely; Shilchar's export-oriented cost structure may not be competitive on pure domestic.
Guidance credibility
MediumAnnual report (July, prepared June) was optimistic on West Asia recovery; Q1 showed 60-65% utilization and 229 bps margin miss. Management wrong-footed on macro assumption; ₹800 Cr FY27 target increasingly difficult to believe after 15% YoY revenue decline.
Management
Score 6/10. Moderate transparency. Management quantified revenue loss (₹30-35 Cr) and cost pass-through (50-60%), but evasive on order book margin profile ('reasonable margins' without specifics). Deferred segment breakup and working capital to offline follow-up. Defensive tone on Q1 execution and timing mismatch with annual report. Mixed track record. Acknowledged wrong assumption on West Asia resolution (June vs Q1 reality). Capacity utilization 60-65% vs FY27 target 'near 100%' suggests either over-confidence or demand surprise. Custom product lead time (10-16 weeks) cited as reason for slow domestic pivot, but critics noted competitors managed better on shorter cycle.
1 · Q2 FY27 (Jul-Sep 2026)
Management expects 'notably better' momentum; ₹500 Cr OB execution begins; shipping cost normalization critical
2 · Apr 2027
Phase-3 capacity (6,500 MVA) commissioned; 220 KV product market entry; 3-4 month prototyping ramp
3 · West Asia resolution
If conflict ends and shipping normalizes, export order backlog unfreezes; margin recovery path
Key risk: if West Asia crisis persists and export share remains ~30%, FY27 margin guidance credibility erodes further.